SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
Shawna Nesbitt, MD
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Javed Butler
Closing Gaps in Care for Patients with T2D & CV Disease
John Buse, MD, PhD
Jennifer B. Green, MD
What to Know About the No Surprises Act
Charles Turck, PharmD, BCPS, BCCCP
Emily Carroll, JD, MSW
Assessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
John E. Anderson, MD
Simon Heller, MD
Hypoglycemia & the Cardiovascular System: An Inside Look at Emerging Clinical Trial Data
Dissecting Clinical Trial Data from the 81st Scientific Sessions
Carol Wysham
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
Anne Louise Peters, MD
Detecting & Diagnosing Diabetes in Cardiology Patients
Matthew J. Sorrentino, MD, FACC, FASH
Alan S. Brown, MD, FACC, FAHA, FNLA
A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
Linda Bernstein, Pharm.D.
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.